Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade

Overview of attention for article published in Cancer Discovery, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 82 X users
patent: 1 patent

f1000: 1 research highlight platform

Readers on

mendeley: 71 Mendeley

So far, Altmetric has seen 151 X posts from 82 X users, with an upper bound of 508,040 followers.

The clinical research landscape for pancreatic cancer has progressively transformed, with stereotactic body radiotherapy (SBRT) combined with focal adhesion kinase inhibitors (FAKi) emerging as a promising therapeutic strategy. • This approach has been f…

@Mat_Guc NCT04331041 • Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade #PDAC #SBRT 🎯 #FAK 🔸️ https://t.co/VDbQ2U60He https://t.co/McJiPDO2d7

RT @DeNardoLabWUSM: Congratulations to Varintra Lander and team on Cancer Discovery paper now online! Stromal reprogramming by FAK inhibit…

RT @CrozrX: Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint B…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 147 additional X posts.